Study will generate a key reference data set with Illumina Protein Prep solution SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank...
Read More Details
Finally We wish PressBee provided you with enough information of ( Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples )
Also on site :